Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways

Both tumor hypoxia and dysregulated metabolism are classical features of cancer. Recent analyses have revealed complex interconnections between oncogenic activation, hypoxia signaling systems and metabolic pathways that are dysregulated in cancer. These studies have demonstrated that rather than responding simply to error signals arising from energy depletion or tumor hypoxia, metabolic and hypoxia signaling pathways are also directly connected to oncogenic signaling mechanisms at many points. This review will summarize current understanding of the role of hypoxia inducible factor (HIF) in these networks. It will also discuss the role of these interconnected pathways in generating the cancer phenotype; in particular, the implications of switching massive pathways that are physiologically 'hard-wired’ to oncogenic mechanisms driving cancer.

• Publication year

  2014

• Venue

  Cancer & Metabolism

• Publication date

  2014-02-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/2049-3002-2-3PMID 24491179PMCID 3938304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.

  2013cited by this paper
• The Emerging Role of D-2-Hydroxyglutarate as an Oncometabolite in Hematolymphoid and Central Nervous System Neoplasms

  2013cited by this paper
• Prolyl 4‐hydroxylases, master regulators of the hypoxia response

  2013cited by this paper
• Akt-dependent Activation of the Heart 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase (PFKFB2) Isoenzyme by Amino Acids*

  2013cited by this paper
• In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation.

  2013cited by this paper
• The VHL/HIF axis in clear cell renal carcinoma.

  2013cited by this paper
• What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.

  2013cited by this paper
• Positive feedback loop and synergistic effects between hypoxia‐inducible factor‐2α and stearoyl–CoA desaturase‐1 promote tumorigenesis in clear cell renal cell carcinoma

  2013cited by this paper
• Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer

  2013cited by this paper
• Regulation of CLL survival by hypoxia‐inducible factor and its target genes

  2012cited by this paper
• Oxygen versus Reactive Oxygen in the Regulation of HIF-1α: The Balance Tips

  2012cited by this paper
• The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity

  2012cited by this paper
• Glycogen Synthesis is Induced in Hypoxia by the Hypoxia-Inducible Factor and Promotes Cancer Cell Survival

  2012cited by this paper
• Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

  2012cited by this paper
• Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.

  2012influential reference
• HIF-independent role of prolyl hydroxylases in the cellular response to amino acids

  2012cited by this paper
• Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis

  2012cited by this paper
• Inhibition of SIRT1 Impairs the Accumulation and Transcriptional Activity of HIF-1α Protein under Hypoxic Conditions

  2012cited by this paper
• REDD1 (regulated in development and DNA damage responses 1) is a central regulator of hepatic injury following liver ischemia-reperfusion (I/R)

  2012cited by this paper
• Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

  2012cited by this paper
• Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation

  2012cited by this paper
• Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism

  2012cited by this paper
• Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression

  2012cited by this paper
• IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives

  2012cited by this paper
• HIF1α Protein Stability Is Increased by Acetylation at Lysine 709*

  2012cited by this paper
• M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth

  2012cited by this paper
• Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron.

  2012cited by this paper
• Reciprocal influence of the p53 and the hypoxic pathways

  2011cited by this paper
• Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.

  2011cited by this paper
• THE METABOLISM OF CARCINOMA CELLS

  2011cited by this paper
• Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases.

  2011cited by this paper
• Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors*

  2011cited by this paper
• Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival

  2011cited by this paper
• Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity.

  2011cited by this paper
• SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization.

  2011cited by this paper
• Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

  2011cited by this paper
• Reductive carboxylation supports growth in tumor cells with defective mitochondria

  2011influential reference
• Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

  2011cited by this paper
• Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene.

  2011cited by this paper
• Vitamin C is dispensable for oxygen sensing in vivo.

  2011cited by this paper
• The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases

  2011cited by this paper
• Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner*

  2011cited by this paper
• Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment

  2011cited by this paper
• Evolutionary Conserved Regulation of HIF-1β by NF-κB

  2011cited by this paper
• Hypoxia‐inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia‐inducible factor‐1

  2010cited by this paper
• 12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells.

  2010cited by this paper
• Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis

  2010cited by this paper
• Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism.

  2010cited by this paper
• The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.

  2010cited by this paper
• Hypoxia Promotes Glycogen Accumulation through Hypoxia Inducible Factor (HIF)-Mediated Induction of Glycogen Synthase 1

  2010cited by this paper
• HIF-1: upstream and downstream of cancer metabolism.

  2010cited by this paper
• Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer.

  2010cited by this paper
• Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.

  2010cited by this paper
• Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma

  2010cited by this paper
• The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

  2010cited by this paper
• Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells

  2010cited by this paper
• Glucose is necessary for stabilization of hypoxia‐inducible factor‐1α under hypoxia: Contribution of the pentose phosphate pathway to this stabilization

  2010cited by this paper
• Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.

  2010cited by this paper
• MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU

  2010cited by this paper
• Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1

  2009cited by this paper
• Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy.

  2009cited by this paper
• Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

  2009cited by this paper
• MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.

  2009cited by this paper
• Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.

  2009cited by this paper
• Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events

  2009cited by this paper
• HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.

  2009cited by this paper
• Cancer cell metabolism: Warburg and beyond.

  2008cited by this paper
• Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.

  2008cited by this paper
• Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells.

  2008cited by this paper
• Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.

  2008influential reference
• The interplay between MYC and HIF in cancer

  2008cited by this paper
• PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia

  2008cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2*

  2008cited by this paper
• The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer

  2008cited by this paper
• Mitochondrial complex III regulates hypoxic activation of HIF

  2008cited by this paper
• Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia*

  2008cited by this paper
• Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.

  2008cited by this paper
• HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.

  2007cited by this paper
• Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1α and Mediates Its Destabilization in a VHL-Independent Manner

  2007cited by this paper
• HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.

  2007cited by this paper
• Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.

  2007cited by this paper
• Structural and Mechanistic Studies on the Inhibition of the Hypoxia-inducible Transcription Factor Hydroxylases by Tricarboxylic Acid Cycle Intermediates*

  2007cited by this paper
• Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

  2007cited by this paper
• NAD(P)H Oxidases Regulate HIF-2α Protein Expression*

  2007cited by this paper
• Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates

  2007influential reference
• Reactive Oxygen Species Activate the HIF-1&agr; Promoter Via a Functional NF&kgr;B Site

  2007cited by this paper
• HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells.

  2007cited by this paper
• NAD(P)H oxidases regulate HIF-2alpha protein expression.

  2007influential reference
• HIF-dependent antitumorigenic effect of antioxidants in vivo.

  2007cited by this paper
• Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations

  2007cited by this paper
• Aerobically Derived Lactate Stimulates Revascularization and Tissue Repair via Redox Mechanisms

  2007cited by this paper
• [Oxidative stress].

  2007cited by this paper
• Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site.

  2007cited by this paper
• Akt1 Activation Can Augment Hypoxia-Inducible Factor-1α Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin–Independent Pathway

  2006cited by this paper
• Hypoxia-induced energy stress regulates mRNA translation and cell growth.

  2006cited by this paper
• The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism*

  2006cited by this paper
• HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

  2006cited by this paper

• Metabolic crosstalk in the metastatic prostate cancer-bone microenvironment: mechanism, detection and therapeutic strategies.

  2026cites this paper
• From Dimerization to Signaling: Molecular Dynamics Insights into EphA1 and EphA2 Isoform Specificity

  2025cites this paper
• Heterogeneous expression of BMP7, HIF-2α, Ki-67, and E-Cadherin in clear cell renal carcinoma: Prognostic implications based on tumor region.

  2025cites this paper
• The molecular basis of punctuated equilibria: the roles of developmental genes in stasis and speciation

  2025cites this paper
• Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases

  2025cites this paper
• Metabolic Reprogramming as a Therapeutic Target in Cancer: A Qualitative Systematic Review (QualSR) of Natural Compounds Modulating Glucose and Glutamine Pathways

  2025cites this paper
• Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis

  2025cites this paper
• Research progress of the Otubains subfamily in hepatocellular carcinoma.

  2024cites this paper
• Research progress of RP1L1 gene in disease.

  2024cites this paper
• Glucose deprivation impairs hypoxia-inducible factor-1α synthesis

  2024cites this paper
• ATF4 in cellular stress, ferroptosis, and cancer

  2024cites this paper
• Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study

  2024cites this paper
• A gene for all seasons: The evolutionary consequences of HIF-1 in carcinogenesis, tumor growth and metastasis.

  2024cites this paper
• Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

  2024cites this paper
• Transcriptomic profiling of healthy individual-derived LCLs revealed inter-individual variability towards-hypoxia-responsive pathways

  2024cites this paper
• Insights into metabolic heterogeneity of colorectal cancer gained from fluorescence lifetime imaging

  2024cites this paper
• Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: from mechanisms to therapy.

  2024cites this paper
• Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche

  2024cites this paper
• Lipid metabolism reprogramming in renal cell carcinomas

  2024cites this paper
• Tumor Metabolic Heterogeneity

  2023cites this paper
• Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

  2023cites this paper
• Glycine Decarboxylase (GLDC) Plays a Crucial Role in Regulating Energy Metabolism, Invasion, Metastasis and Immune Escape for Prostate Cancer

  2023cites this paper
• Hemidesmus indicus (L.) R. Br. ex Schult as natural bioactive products: An evidence-based review focused on inflammation related cancer prevention potential

  2023cites this paper
• Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma

  2023cites this paper
• Somatic EPAS1 Variants in Pheochromocytoma and Paraganglioma in Patients With Sickle Cell Disease

  2023cites this paper
• HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia.

  2023cites this paper
• Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview

  2023cites this paper
• Metabolic Heterogeneity of Tumors

  2023cites this paper
• Redox-Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities and Challenges.

  2023cites this paper
• Major roles of the circadian clock in cancer

  2023cites this paper
• HIF-2 Regulation of Amino Acid Transporter Expression in Hepatocellular Carcinoma Cells

  2023cites this paper
• Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia

  2023cites this paper
• The Role of Reprogrammed Glucose Metabolism in Cancer

  2023cites this paper
• A Proposed Association between Improving Energy Metabolism of HepG2 Cells by Plant Extracts and Increasing Their Sensitivity to Doxorubicin

  2023cites this paper
• Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis

  2023cites this paper
• A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

  2022cites this paper
• Exosomes Derived from Bone Marrow Mesenchymal Stem Cells (BMSCs) Inhibit the Invasion and Metastasis of Ovarian Cancer by Regulating Epithelial-Mesenchymal Transition Under Hypoxic Microenvironment

  2022cites this paper
• The Role of Hypoxia-Inducible Factor Isoforms in Breast Cancer and Perspectives on Their Inhibition in Therapy

  2022influential citation
• Mitophagy: A novel perspective for insighting into cancer and cancer treatment

  2022cites this paper
• Advanced nanomedicines for the regulation of cancer metabolism.

  2022cites this paper
• Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine

  2022cites this paper
• Targeting metabolism: A potential strategy for hematological cancer therapy

  2022cites this paper
• Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment.

  2022cites this paper
• Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer

  2022cites this paper
• Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis

  2022cites this paper
• Shining a Light on Cancer—Photonics in Microfluidic Tumor Modeling and Biosensing

  2022cites this paper
• PROTACs technology for treatment of Alzheimer's disease: Advances and perspectives.

  2022cites this paper
• The role of redox homeostasis biomarkers in clear cell renal cell carcinoma development and progression

  2022cites this paper
• NF-κB1 p50 stabilizes HIF-1α protein through suppression of ATG7-dependent autophagy

  2022cites this paper
• New Affordable Methods for Large-Scale Isolation of Major Olive Secoiridoids and Systematic Comparative Study of Their Antiproliferative/Cytotoxic Effect on Multiple Cancer Cell Lines of Different Cancer Origins

  2022cites this paper
• Decrease of Intracellular Glutamine by STF-62247 Results in the Accumulation of Lipid Droplets in von Hippel-Lindau Deficient Cells

  2022cites this paper
• Understanding the link between kidney stones and cancers of the upper urinary tract and bladder.

  2022cites this paper
• Morphological Assessment and Biomarkers of Low-Grade, Chronic Intestinal Inflammation in Production Animals

  2022cites this paper
• Regulation of Lipid Metabolism Under Stress and Its Role in Cancer.

  2022cites this paper
• The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors

  2022cites this paper
• Inducing vascular normalization: A promising strategy for immunotherapy.

  2022cites this paper
• Hypoxia-Induced MALAT1 Promotes the Proliferation and Migration of Breast Cancer Cells by Sponging MiR-3064-5p

  2021cites this paper
• Biocompatible Ir(III) Complexes as Oxygen Sensors for Phosphorescence Lifetime Imaging

  2021cites this paper
• High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor

  2021cites this paper
• Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

  2021cites this paper
• Construction of cancer-on-a-chip for drug screening.

  2021cites this paper
• Regulation of Autophagy Enzymes by Nutrient Signaling.

  2021cites this paper
• The Intratumoral Heterogeneity of Cancer Metabolism.

  2021cites this paper
• ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells

  2021cites this paper
• Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons

  2021cites this paper
• Mitochondria autophagy: a potential target for cancer therapy

  2021cites this paper
• Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis.

  2021cites this paper
• Immune Infiltration Landscape in Clear Cell Renal Cell Carcinoma Implications

  2021cites this paper
• Tumor microenvironment and radioresistance

  2021cites this paper
• Case Series of Hepatocellular Carcinoma with the Atypical Contrast-Enhancement Ultrasound Enhancement Patterns and a Review of the Literature

  2021cites this paper
• Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression

  2021influential citation
• Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer

  2021cites this paper
• Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Role of succinylation modification in thyroid cancer and breast cancer.

  2021cites this paper
• Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins

  2021cites this paper
• Lung Adenocarcinoma Transcriptomic Analysis Predicts Adenylate Kinase Signatures Contributing to Tumor Progression and Negative Patient Prognosis

  2021cites this paper
• System Biology and Network Analysis Approaches on Oxidative Stress in Cancer

  2021cites this paper
• Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90

  2021cites this paper
• The effect of hypoxia on the secretome of human glioblastoma multiforme cells

  2021cites this paper
• Lipid metabolism reprogramming in renal cell carcinoma

  2021cites this paper
• Melatonin and hyperbaric oxygen therapies suppress colorectal carcinogenesis through pleiotropic effects and multifaceted mechanisms

  2021cites this paper
• VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway

  2021cites this paper
• Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning

  2021cites this paper
• Siglec Signaling in the Tumor Microenvironment

  2021cites this paper
• Влияние гипоксии на секретом клеток мультиформной глиобластомы человека

  2021cites this paper
• SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization

  2021cites this paper
• Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma

  2020cites this paper
• GENE EXPRESSION PROFILING AND CLINICAL RELEVANCE TO UNDERSTAND THE ROLE OF HYPOXIA AND IMMUNE SIGNALING GENES AND PATHWAYS IN BREAST CANCER

  2020cites this paper
• A mark of disease: how mRNA modifications shape genetic and acquired pathologies

  2020cites this paper
• Status Quo of Glycosylation in Cancer: What Is, What Is Not and What Is to Be

  2020cites this paper
• Single-cell genomic profile-based analysis of tissue differentiation in colorectal cancer

  2020cites this paper
• Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression

  2020cites this paper
• Advances in nanomaterials for treatment of hypoxic tumor

  2020cites this paper
• Chemo-sensitizing agents from natural origin for colorectal cancer: Pharmacodynamic and cellular pharmacokinetics approaches

  2020cites this paper
• SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers

  2020cites this paper
• Hypoxia, Hypoxia-Inducible Gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer.

  2020cites this paper
• Endocytosis in the adaptation to cellular stress

  2020cites this paper
• HIF1α inhibition by dual targeting of CDK4/6 and HSP90 reduces cancer cell viability including Rb-deficient cells

  2020cites this paper
• Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress

  2020cites this paper